Overview


Clinical trials are a form of research that evaluates the effects of new treatments and tests on human health. Clinical trials are open to anyone willing to participate in medical research. These include drugs, biological products, radiological procedures, and devices. Before clinical trials can begin, they must be carefully planned, reviewed, and approved. Clinical trials are open to all ages, even children. A clinical trial is designed to test whether a new treatment, test, or potential drug or medical device works and is safe. A clinical trial is a way to determine the best medical approach to treating life-threatening conditions such as diabetes, cancer, heart disease, and HIV/AIDS. There are many possible treatments, including drugs, medical devices, and vaccines. In recent years, the number of clinical trials registered has increased dramatically. The research and development of new products and drugs have been made more complicated by clinical trials. The pharmaceutical industry is the industry that spends the most on research and development. Due to increasing demand for efficient logistics, supply chain management, and temperature control management, clinical trials are being outsourced more frequently. Global biopharmaceutical spending has increased significantly on cold chain logistics. This trend is expected to continue and will drive the clinical trials supply and logistics market. This has increased outsourcing activities such as material supplies, packaging, and blinding. Due to the high rate of drug candidates being developed, drug discovery and development can be costly.

Drug research and development can fail because of the difficulty involved in rare disease research. The market is expected to grow as more medical devices, drugs, and therapies are developed. The global logistics and clinical trial supply market is strongly influenced by technological advances in pharmaceutical and biologics. Many companies are investing heavily to improve logistics and technology in clinical trial activities, thereby increasing the supply of equipment. Many governments encourage ethical clinical trial activities that will benefit humanity. The global logistics and clinical trial supply market is set to grow at an incredible rate in the near future. The demand for efficient logistics and clinical trial supply is growing simultaneously with manufacturers' increasing focus on minimizing overage and avoiding shortages, optimizing manufacturing and packaging, and balancing shipping and supply costs. The main factors that hinder the supply and logistics of clinical trials are high costs for patients and equipment, as well as lack of expertise and time consumption. These issues are likely to be faced by many players who want to expand into new markets. Innovations in clinical trial supply and logistics. Supply and logistics providers, as well as pharmaceutical or biotech companies, are actively involved in finding alternative site solutions and using more innovative approaches to keep trials moving forward. This will prevent delays in therapies and ensure that patients can benefit from them. This pandemic is the first to disrupt traditional onsite clinical trials.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Clinical Trial Supply and Logistics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Clinical Trial Supply and Logistics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  •  World Courier
  •  DHL
  •  Mobianto
  •  Catalent
  •  Patheon
  •  Marken
  •  FedEx
  •  Almac Group
  •  Parexel International
  •  Fisher Clinical Services
  •  Packaging Corodinators Inc.
  •  Thermo Fisher Scientific
  •  Eurofins
  •  PRA Health Sciences
  •  Avomeen Analytical Services Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Service

  •  Manufacturing
  •  Storage and Retention
  •  Packaging, Labeling, and Binding
  •  Logistics and Distribution
  •  Comparator Sourcing
  •  Other Services

By Phase

  •  Phase I
  •  Phase II
  •  Phase III
  •  Phase IV

By End User

  •  Pharmaceutical and Biotech Organistions
  •  Medical Devices and Supplier Companies

By Clinical Trial Type

  •  Therapeutic and Prevention
    •  Vaccines
    •  Drug Discovery and Development
    •  Therapeutic Devices
    •  Biosimilars
    •  Therapeutic Assays
    •  Therapeutic Procedures
  •  Diagnostics
    •  Diagnostic Assay
    •  Diagnostic Devices

By Therpaeutic Area

  •  Oncology
  •  CNS and Mental Disorders
  •  Diabetes
  •  Cardiovascular Diseases
  •  Dermatology
  •  Respiratory Diseases
  •  Blood Disorders
  •  Gastrointestinal Diseases
  •  Infectious Diseases
  •  Ophthalmology
  •  Rare Diseases
  •  Other Therapeutic Areas

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth

  •  To provide with an exhaustive analysis on the Clinical Trial Supply and Logistics Market By Service, By Phase, By End User, By Clinical Trial Type, By Therpaeutic Area and By Region.
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Clinical Trial Supply and Logistics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Clinical Trial Supply and Logistics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.   Clinical Trial Supply and Logistics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.   Clinical Trial Supply and Logistics Market, By Service Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Manufacturing
        2. Storage and Retention
        3. Packaging, Labeling, and Binding
        4. Logistics and Distribution
        5. Comparator Sourcing
        6. Other Services

  • 8.   Clinical Trial Supply and Logistics Market, By Phase Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Phase I
        2. Phase II
        3. Phase III
        3. Phase IV

  • 9.   Clinical Trial Supply and Logistics Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Pharmaceutical and Biotech Organisations
        2. Medical Devices and Supplier Companies

  • 10.   Clinical Trial Supply and Logistics Market, By Clinical Trial Types Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Therapeutic and Prevention
         1.1. Vaccines
         1.2. Drug Discovery and Development
         1.3. Therapeutic Devices
         1.4. Biosimilars
         1.5. Therapeutic Assays
         1.6. Therapeutic Procedures
        2. Diagnostics
         2.1. Diagnostic Assay
         2.2. Diagnostic Devices

  • 11.   Clinical Trial Supply and Logistics Market, By Therpaeutic Area Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Oncology
        2. CNS and Mental Disorders
        3. Diabetes
        4. Cardiovascular Diseases
        5. Dermatology
        6. Respiratory Diseases
        7. Blood Disorders
        8. Gastrointestinal Diseases
        9. Infectious Diseases
        9. Ophthalmology
        10. Rare Diseases
        11. Other Therapeutic Areas

  • 12.   North America Clinical Trial Supply and Logistics Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 13.   Latin America Clinical Trial Supply and Logistics Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 14.   Europe Clinical Trial Supply and Logistics Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 15.   Asia Pacific Clinical Trial Supply and Logistics Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 16.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. World Courier
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. DHL
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Mobianto
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Catalent
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Patheon
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Marken
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. FedEx
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Almac Group
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Parexel International
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Fisher Clinical Services
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Packaging Corodinators Inc
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Thermo Fisher Scientific
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Eurofins
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. PRA Health Sciences
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Avomeen Analytical Services Inc
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients